320 related articles for article (PubMed ID: 16504838)
1. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Takebayashi K; Matsumoto S; Aso Y; Inukai T
J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.
Wang QY; Chen FQ
Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668
[TBL] [Abstract][Full Text] [Related]
3. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
[TBL] [Abstract][Full Text] [Related]
4. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
Kim CS; Park HS; Kawada T; Kim JH; Lim D; Hubbard NE; Kwon BS; Erickson KL; Yu R
Int J Obes (Lond); 2006 Sep; 30(9):1347-55. PubMed ID: 16534530
[TBL] [Abstract][Full Text] [Related]
5. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
[TBL] [Abstract][Full Text] [Related]
6. The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia.
Takebayashi K; Matsumoto S; Wakabayashi S; Inukai Y; Matsutomo R; Aso Y; Inukai T
Metabolism; 2005 Sep; 54(9):1225-9. PubMed ID: 16125534
[TBL] [Abstract][Full Text] [Related]
7. Cardiorenal risk prevalence in sickle cell hemoglobinopathy.
Abo-Zenah H; Moharram M; El Nahas AM
Nephron Clin Pract; 2009; 112(2):c98-c106. PubMed ID: 19390209
[TBL] [Abstract][Full Text] [Related]
8. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus.
Takebayashi K; Suetsugu M; Wakabayashi S; Aso Y; Inukai T
Metabolism; 2007 Apr; 56(4):451-8. PubMed ID: 17378999
[TBL] [Abstract][Full Text] [Related]
9. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Diabetes Metab Res Rev; 2008 Feb; 24(2):109-14. PubMed ID: 17694504
[TBL] [Abstract][Full Text] [Related]
10. Morning home blood pressure may be a significant marker of nephropathy in Japanese patients with type 2 diabetes: ADVANCED-J study 1.
Tanaka Y; Daida H; Imai Y; Miyauchi K; Sato Y; Hiwatari M; Kitagawa A; Kishimoto J; Yamazaki T; Kawamori R
Hypertens Res; 2009 Sep; 32(9):770-4. PubMed ID: 19557003
[TBL] [Abstract][Full Text] [Related]
11. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.
Navarro JF; Mora C; Muros M; García J
Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891
[TBL] [Abstract][Full Text] [Related]
12. Intensive insulin therapy decreases urinary MCP-1 and ICAM-1 excretions in incipient diabetic nephropathy.
Ye SD; Zheng M; Zhao LL; Qian Y; Yao XM; Ren A; Li SM; Jing CY
Eur J Clin Invest; 2009 Nov; 39(11):980-5. PubMed ID: 19663918
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term pravastatin treatment on serum and urinary monocyte chemoattractant protein-1 levels and renal function in type 2 diabetic patients with normoalbuminuria.
Fujita H; Koshimura J; Sato T; Miura T; Sasaki H; Morii T; Narita T; Kakei M; Ito S; Yamada Y
Ren Fail; 2007; 29(7):791-6. PubMed ID: 17994445
[TBL] [Abstract][Full Text] [Related]
14. Is increasing urinary albumin a better marker for microvascular than for macrovascular complication of type 2 diabetes mellitus?
Herrera-Pombo JL; Aguilar-Diosdado M; Hawkins F; Campos MM; Moreno A; Garcia-Hernandez A; Castro E; García-Doncel LG; Serraclara A; Sánchez-Malo C; Escobar-Jiménez F
Nephron Clin Pract; 2005; 101(3):c116-21. PubMed ID: 16015000
[TBL] [Abstract][Full Text] [Related]
15. Microalbuminuria in essential hypertensives in treatment for hypertension.
Cruz HM; Cruzera AB; Cruz J
Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(5):258-62. PubMed ID: 9595780
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy.
Shaker OG; Sadik NA
Hum Exp Toxicol; 2013 Oct; 32(10):1089-96. PubMed ID: 23515495
[TBL] [Abstract][Full Text] [Related]
17. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy.
Banu N; Hara H; Egusa G; Yamakido M
Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578
[TBL] [Abstract][Full Text] [Related]
18. Coronary arterial calcification is associated with albuminuria in type 2 diabetic patient.
Yamagami K; Hosoi M; Yamamoto T; Fukumoto M; Yamakita T; Miyamoto M; Yoshioka K; Ishii T; Sato T; Tanaka S; Fujii S
Diabetes Obes Metab; 2005 Jul; 7(4):390-6. PubMed ID: 15955125
[TBL] [Abstract][Full Text] [Related]
19. Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes.
Kang ES; Kim HJ; Ahn CW; Park CW; Cha BS; Lim SK; Kim KR; Lee HC
Diabetes Res Clin Pract; 2005 Aug; 69(2):151-9. PubMed ID: 16005364
[TBL] [Abstract][Full Text] [Related]
20. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
Chacón MR; Fernández-Real JM; Richart C; Megía A; Gómez JM; Miranda M; Caubet E; Pastor R; Masdevall C; Vilarrasa N; Ricard W; Vendrell J
Obesity (Silver Spring); 2007 Mar; 15(3):664-72. PubMed ID: 17372317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
